News & Insights
Bipartisan Legislation Introduced to Regulate Hemp-Derived CBD
On July 20, 2023, the Hemp Access and Consumer Safety Act was reintroduced in the U.S. Congress. The long-awaited legislation, originally introduced in 2021, would require the U.S. Food and Drug Administration (FDA) to regulate ingestible hemp-derived cannabidiol (CBD) products the same as other foods, beverages, and dietary supplements.
Understanding the FDA’s New Guidelines for Psychedelic Drug Development and Research
The Food and Drug Administration (FDA) released draft guidance for researchers to consider when conducting clinical trials of the therapeutic benefits of psychedelic drugs.